Overall Technical outlook

Price Summary

On 2025-10-17, Jubilant Pharmova Limited's stock opened at 1076.0, peaked at 1082.9, hit a low of 1064.7, and closed 0.35% up at 1079.8, with 67055 shares changing hands.
The stock's highest value over the last 52 weeks is 1254.55, and the lowest value is 828.1.

Technicals

Support and Resistance: At 1079.8, the price is held up by support at 1053.7 and faces resistance at 1094.2 for JUBLPHARMA. This suggests a trading range where 1053.7 provides a base and 1094.2 limits upward movement.
JUBLPHARMA supportResistance 72eb1f
Support/Resistance for JUBLPHARMA


Aroon: The AROON is in a neutral stance, with no clear direction indicated for the market. This lack of clarity suggests that the market may be in a state of equilibrium for JUBLPHARMA, with no strong trend emerging.
JUBLPHARMA aroon 72eb1f
Aroon chart for Jubilant Pharmova Limited


Bol. Bands: The current reading of the BOLL BANDS indicator suggests a neutral stance, with no clear signals indicating an upward or downward direction. This lack of directional bias suggests the market may be in a period of consolidation or uncertainty.
JUBLPHARMA bbands 72eb1f
Bolinger Bands chart for Jubilant Pharmova Limited


Parabolic SAR: The PSAR maintains a bearish outlook, setting a key resistance level that could limit further gains. This resistance reinforces the bearish sentiment, indicating that the market may face challenges in pushing higher.
JUBLPHARMA psar 72eb1f
Parabolic Stop and Reverse chart for Jubilant Pharmova Limited


Stochastic: The STOCHASTIC is showing a neutral stance, with no definitive indication of an upward or downward trend for JUBLPHARMA. This neutral position suggests a period of indecision in the market, making it difficult to predict the next move.
JUBLPHARMA stoch 72eb1f
Stochastic chart for Jubilant Pharmova Limited


Tripple Moving Agerage: The Tripple MOVING AVG is currently neutral, offering no clear guidance on market direction. This suggests that the market may be in a state of pause, with no strong trend emerging.
JUBLPHARMA trippleSMA 72eb1f
Tripple SMA chart for Jubilant Pharmova Limited


When analyzing a company, its fundamentals—such as earnings, management efficiency, and strategic initiatives—must be considered alongside technical data. The context of the industry in which the company operates also plays a key role, as market trends and competitive dynamics can significantly impact performance. By taking a comprehensive approach, combining both fundamental and technical analysis, one can gain a deeper understanding of the company's potential for growth or risk.